BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6160893)

  • 1. Cutaneous T cell lymphoma: characterization by monoclonal antibodies.
    Kung PC; Berger CL; Goldstein G; LoGerfo P; Edelson RL
    Blood; 1981 Feb; 57(2):261-6. PubMed ID: 6160893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Orthoclone monoclonal antibodies in the study of selected dermatologic conditions.
    Berger CL; Kung P; Goldstein G; DePietro W; Takezaki S; Chu A; Fithian E; Edelson RL
    Int J Immunopharmacol; 1981; 3(3):275-82. PubMed ID: 6974710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood and lymph node T-lymphocyte subsets in non-Hodgkin lymphomas.
    Lindemalm C; Mellstedt H; Biberfeld P; Björkholm M; Christensson B; Holm G; Johansson B; Sundblad R
    Scand J Haematol; 1983 Jan; 30(1):68-78. PubMed ID: 6601285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of monoclonal antibodies specific for T cell subsets in cutaneous disorders: II. Immunomorphological studies in blood and skin lesions.
    Schmitt D; Thivolet J
    J Clin Immunol; 1982 Jul; 2(3 Suppl):111S-119S. PubMed ID: 6982276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cellular content of non Hodgkin lymphomas: a comprehensive analysis using monoclonal antibodies and other surface marker techniques.
    Habeshaw JA; Bailey D; Stansfeld AG; Greaves MF
    Br J Cancer; 1983 Mar; 47(3):327-51. PubMed ID: 6338896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of cutaneous T cell lymphoma by use of monoclonal antibodies reactive with tumor-associated antigens.
    Berger CL; Morrison S; Chu A; Patterson J; Estabrook A; Takezaki S; Sharon J; Warburton D; Irigoyen O; Edelson RL
    J Clin Invest; 1982 Dec; 70(6):1205-15. PubMed ID: 6217214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of specific cell-mediated cytotoxicity by monoclonal antibodies to human T cell antigens.
    Platsoucas CD; Good RA
    Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4500-4. PubMed ID: 6974866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell surface marker studies in a patient with cutaneous multilobated T-cell lymphoma.
    Fattorossi A; Moretti S; Palermo A; Santucci M; Bondi R; Giannotti B
    Br J Dermatol; 1985 Nov; 113(5):587-96. PubMed ID: 3904811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discrete stages of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage.
    Reinherz EL; Kung PC; Goldstein G; Levey RH; Schlossman SF
    Proc Natl Acad Sci U S A; 1980 Mar; 77(3):1588-92. PubMed ID: 6966400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenic modulation of pan-T-cell and T-cell subset-specific markers.
    Estabrook A; Mittler R; LoGerfo P; Hardy M; Edelson RL; Berger CL
    Diagn Immunol; 1983; 1(3):199-204. PubMed ID: 6209055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic characterization of a helper T-cell lymphoma.
    Gramatzki M; Dolan MF; Fauci AS; Maples JA; Bonnard GD; Strong DM
    Blood; 1982 Apr; 59(4):702-8. PubMed ID: 6977388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular identification of human T-lymphocyte antigens defined by the OKT5 and OKT8 monoclonal antibodies.
    Phan-Dinh-Tuy F; Niaudet P; Bach JF
    Mol Immunol; 1982 Dec; 19(12):1649-54. PubMed ID: 6761583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunoarchitecture of cutaneous pseudolymphoma.
    Wirt DP; Grogan TM; Jolley CS; Rangel CS; Payne CM; Hansen RC; Lynch PJ; Schuchardt M
    Hum Pathol; 1985 May; 16(5):492-510. PubMed ID: 3157635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does OKT3 monoclonal antibody react with an antigen-recognition structure on human T cells?
    Chang TW; Kung PC; Gingras SP; Goldstein G
    Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1805-8. PubMed ID: 6165018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human T lymphocyte subpopulations defined by Fc receptors and monoclonal antibodies. A comparison.
    Reinherz EL; Moretta L; Roper M; Breard JM; Mingari MC; Cooper MD; Schlossman SF
    J Exp Med; 1980 Apr; 151(4):969-74. PubMed ID: 6445397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant lymphoma with dual B and T cell markers. Analysis of the neoplastic cells with monoclonal antibodies directed against T cell subsets.
    Aisenberg AC; Bloch KJ; Wilkes BM
    J Exp Med; 1981 Nov; 154(5):1709-14. PubMed ID: 6975352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic characterization of skin-infiltrating T cells in cutaneous T-cell lymphoma: comparison with benign cutaneous T-cell infiltrates.
    Haynes BF; Hensley LL; Jegasothy BV
    Blood; 1982 Aug; 60(2):463-73. PubMed ID: 7046848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous T-cell lymphoma, multilobated type, expressing membrane differentiation antigens of precursor T-lymphocytes.
    van der Putte SC; Schuurman HJ; Toonstra J
    Br J Dermatol; 1982 Sep; 107(3):293-300. PubMed ID: 6981422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell surface phenotype and in vitro function of adult T-cell leukemia cells.
    Uchiyama T; Hattori T; Wano Y; Tsudo M; Takatsuki K; Uchino H
    Diagn Immunol; 1983; 1(3):150-4. PubMed ID: 6094084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of T lymphocyte subsets in human colostrum.
    Richie ER; Bass R; Meistrich ML; Dennison DK
    J Immunol; 1982 Sep; 129(3):1116-9. PubMed ID: 6980919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.